Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Liaoning Chengda Co's total equity for the quarter that ended in Mar. 2026 was ¥33,167 Mil.
This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.
Liaoning Chengda Co Total Equity Related Terms
Liaoning Chengda Co Total Equity Historical Data
* Premium members only.
The historical data trend for Liaoning Chengda Co's Total Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Liaoning Chengda Co (SHSE:600739) has a Total Equity of ¥33,167 Mil as of Mar. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Liaoning Chengda Co and its competitors.
Is Liaoning Chengda Co's Total Equity too high?
Liaoning Chengda Co's current Total Equity is ¥33,167 Mil. Overall, Liaoning Chengda Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Liaoning Chengda Co's Total Equity compare to MCK and CAH?
Liaoning Chengda Co's Total Equity of ¥33,167 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Distribution company?
A good Total Equity depends on the Medical Distribution industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Liaoning Chengda Co and its competitors. Liaoning Chengda Co's current Total Equity is ¥33,167 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Liaoning Chengda Co stock overvalued right now?
Based on GuruFocus' analysis, Liaoning Chengda Co (SHSE:600739) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥9.70, compared to a current price of ¥10.82 — trading 11.5% above its estimated fair value. The current Total Equity is ¥33,167 Mil. Liaoning Chengda Co's overall GF Score™ is 54/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Liaoning Chengda Co (SHSE:600739), the current Total Equity is ¥33,167 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Liaoning Chengda Co (SHSE:600739) Overvalued in 2026?
Based on GuruFocus' analysis, Liaoning Chengda Co stock appears to be overvalued.
The current stock price of ¥10.82 is trading 11.5% above its estimated GF Value™ of ¥9.70.
GuruFocus considers Liaoning Chengda Co to be Modestly Overvalued.
Key valuation signals for SHSE:600739:
Total Equity: ¥33,167 Mil
GF Value™: ¥9.70 vs. price of ¥10.82 (11.5% above fair value)
No single metric tells the full story. See the SHSE:600739 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Liaoning Chengda Co Ltd is engaged in the business of pharmaceutical and medical, domestic and foreign trade, financial investment, and energy development. The trading division is engaged in the trading of textiles and clothing, steel, wood, and aquatic products. The company is also involved in securities, insurance, and fund business through its financial investment division.
54GF Score
Get the complete analysis for SHSE:600739
Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600739 has been successfully added to your 
